Please enable JavaScript to continue using this application.

Compare $HRTX vs $NMAD | Chartloom

Compare

$HRTX vs $NMAD

Heron Therapeutics Inc · NOMAD Power Solutions, Inc

HRTX

Heron Therapeutics Inc

NMAD

NOMAD Power Solutions, Inc

Compare $HRTX vs $NMAD

Comparing Heron Therapeutics Inc and NOMAD Power Solutions, Inc

HRTXHeron Therapeutics Inc

NMADNOMAD Power Solutions, Inc

HRTXHeron Therapeutics Inc

Market cap

$77M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

1.0%

YTD performance

-67.8%

52W performance

-69.9%

FCF yield

-15.8%

NMADNOMAD Power Solutions, Inc

Market cap

$86M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-38.3%

52W performance

-38.3%

FCF yield

-6.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HRTX

NMAD

Detailed metrics comparison

HRTX

Heron Therapeutics Inc

NMAD

NOMAD Power Solutions, Inc

Market Cap

HRTX$77M

NMAD$86M

Enterprise Value

HRTX$199M

NMAD$73M

Price

HRTX$0.41

NMAD$4.53

P/E Ratio

HRTXN/A

NMADN/A

P/S Ratio

HRTX0.51x

NMAD0.00x

EV/Sales

HRTX1.31x

NMAD0.00x

EV/EBITDA

HRTX79.76x

NMAD0.00x

P/B Ratio

HRTX9.55x

NMAD2.77x

P/FCF Ratio

HRTXN/A

NMADN/A

EV/FCF

HRTX-16.38x

NMAD-13.42x

PEG Ratio

HRTXN/A

NMADN/A

Forward P/E (NTM)

HRTXN/A

NMADN/A

Forward P/S (NTM)

HRTXN/A

NMADN/A

Revenue (TTM)

HRTX$151M

NMAD$0

Revenue Growth (YoY)

HRTX1.0%

NMADN/A

Forward Rev Growth

HRTX-1.6%

NMAD0.0%

Gross Margin (TTM)

HRTX70.1%

NMAD0.0%

Operating Margin (TTM)

HRTX0.0%

NMAD0.0%

EBITDA Margin (TTM)

HRTX-5.8%

NMAD0.0%

Net Margin (TTM)

HRTX-22.5%

NMAD0.0%

FCF Margin (TTM)

HRTX-8.0%

NMADN/A

Net Income (TTM)

HRTX$-34M

NMAD$-9M

FCF (TTM)

HRTX$-12M

NMAD$-5M

EPS (TTM)

HRTX-$0.18

NMAD-$0.65

ROE (TTM)

HRTX-30090.0%

NMAD-7439.0%

ROA (TTM)

HRTX-1357.0%

NMAD-6203.0%

ROIC (TTM)

HRTX-2233.0%

NMAD-7439.0%

Cash

HRTX$21M

NMAD$13M

Debt

HRTX$143M

NMAD$0

Net Cash/Debt

HRTX$-122M

NMAD$13M

Current Ratio (TTM)

HRTX2.49x

NMAD12.87x

Quick Ratio (TTM)

HRTX1.44x

NMAD12.78x

Debt/Equity (TTM)

HRTX20.65x

NMAD0.00x

Debt/Assets (TTM)

HRTX0.0%

NMAD0.0%

Interest Coverage (TTM)

HRTXN/A

NMADN/A

Net Debt/EBITDA (TTM)

HRTX0.00x

NMAD0.00x

Beta

HRTX1.65

NMAD0.87

52W Performance

HRTX-69.9%

NMAD-38.3%

YTD Performance

HRTX-67.8%

NMAD-38.3%

% from 52W High

HRTX-74.3%

NMAD-41.2%

% from 52W Low

HRTX55.6%

NMAD45.2%

Asset Turnover (TTM)

HRTX0.60x

NMAD0.00x

FCF Yield (TTM)

HRTX-15.8%

NMAD-6.4%

Earnings Yield (TTM)

HRTX-44.3%

NMAD-10.1%

Dividend Yield (TTM)

HRTXN/A

NMADN/A

Rule of 40

HRTX-7.0

NMAD0.0

EV/GP/RG

HRTXN/A

NMADN/A

Ticker research

View HRTX research View NMAD research

Metric	HRTX Heron Therapeutics Inc	NMAD NOMAD Power Solutions, Inc
Market & Valuation
Market Cap	$77M	$86M
Enterprise Value	$199M	$73M
Price	$0.41	$4.53
P/E Ratio	N/A	N/A
P/S Ratio	0.51x	0.00x
EV/Sales	1.31x	0.00x
EV/EBITDA	79.76x	0.00x
P/B Ratio	9.55x	2.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.38x	-13.42x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$151M	$0
Revenue Growth (YoY)	1.0%	N/A
Forward Rev Growth	-1.6%	0.0%
Profitability
Gross Margin (TTM)	70.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-5.8%	0.0%
Net Margin (TTM)	-22.5%	0.0%
FCF Margin (TTM)	-8.0%	N/A
Net Income (TTM)	$-34M	$-9M
FCF (TTM)	$-12M	$-5M
EPS (TTM)	-$0.18	-$0.65
ROE (TTM)	-30090.0%	-7439.0%
ROA (TTM)	-1357.0%	-6203.0%
ROIC (TTM)	-2233.0%	-7439.0%
Financial Health
Cash	$21M	$13M
Debt	$143M	$0
Net Cash/Debt	$-122M	$13M
Current Ratio (TTM)	2.49x	12.87x
Quick Ratio (TTM)	1.44x	12.78x
Debt/Equity (TTM)	20.65x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.65	0.87
52W Performance	-69.9%	-38.3%
YTD Performance	-67.8%	-38.3%
% from 52W High	-74.3%	-41.2%
% from 52W Low	55.6%	45.2%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.00x
FCF Yield (TTM)	-15.8%	-6.4%
Earnings Yield (TTM)	-44.3%	-10.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-7.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View HRTX research	View NMAD research

Valuation

P/S Ratio

NMAD

0.00x

HRTX

0.51x

EV/FCF

HRTX

-16.38x

NMAD

-13.42x

Growth & revenue

Revenue Growth TTM

HRTX

1.0%

Forward Revenue Growth

NMAD

0.0%

HRTX

-1.6%

Profitability & performance

Gross Margin

HRTX

70.1%

NMAD

0.0%

ROE

NMAD

-7439.0%

HRTX

-30090.0%

FCF Yield %

NMAD

-6.4%

HRTX

-15.8%

52-Week Performance

NMAD

-38.3%

HRTX

-69.9%

Detailed metrics comparison

HRTX

Heron Therapeutics Inc

NMAD

NOMAD Power Solutions, Inc

Market Cap

HRTX$77M

NMAD$86M

Enterprise Value

HRTX$199M

NMAD$73M

Price

HRTX$0.41

NMAD$4.53

P/E Ratio

HRTXN/A

NMADN/A

P/S Ratio

HRTX0.51x

NMAD0.00x

EV/Sales

HRTX1.31x

NMAD0.00x

EV/EBITDA

HRTX79.76x

NMAD0.00x

P/B Ratio

HRTX9.55x

NMAD2.77x

P/FCF Ratio

HRTXN/A

NMADN/A

EV/FCF

HRTX-16.38x

NMAD-13.42x

PEG Ratio

HRTXN/A

NMADN/A

Forward P/E (NTM)

HRTXN/A

NMADN/A

Forward P/S (NTM)

HRTXN/A

NMADN/A

Revenue (TTM)

HRTX$151M

NMAD$0

Revenue Growth (YoY)

HRTX1.0%

NMADN/A

Forward Rev Growth

HRTX-1.6%

NMAD0.0%

Gross Margin (TTM)

HRTX70.1%

NMAD0.0%

Operating Margin (TTM)

HRTX0.0%

NMAD0.0%

EBITDA Margin (TTM)

HRTX-5.8%

NMAD0.0%

Net Margin (TTM)

HRTX-22.5%

NMAD0.0%

FCF Margin (TTM)

HRTX-8.0%

NMADN/A

Net Income (TTM)

HRTX$-34M

NMAD$-9M

FCF (TTM)

HRTX$-12M

NMAD$-5M

EPS (TTM)

HRTX-$0.18

NMAD-$0.65

ROE (TTM)

HRTX-30090.0%

NMAD-7439.0%

ROA (TTM)

HRTX-1357.0%

NMAD-6203.0%

ROIC (TTM)

HRTX-2233.0%

NMAD-7439.0%

Cash

HRTX$21M

NMAD$13M

Debt

HRTX$143M

NMAD$0

Net Cash/Debt

HRTX$-122M

NMAD$13M

Current Ratio (TTM)

HRTX2.49x

NMAD12.87x

Quick Ratio (TTM)

HRTX1.44x

NMAD12.78x

Debt/Equity (TTM)

HRTX20.65x

NMAD0.00x

Debt/Assets (TTM)

HRTX0.0%

NMAD0.0%

Interest Coverage (TTM)

HRTXN/A

NMADN/A

Net Debt/EBITDA (TTM)

HRTX0.00x

NMAD0.00x

Beta

HRTX1.65

NMAD0.87

52W Performance

HRTX-69.9%

NMAD-38.3%

YTD Performance

HRTX-67.8%

NMAD-38.3%

% from 52W High

HRTX-74.3%

NMAD-41.2%

% from 52W Low

HRTX55.6%

NMAD45.2%

Asset Turnover (TTM)

HRTX0.60x

NMAD0.00x

FCF Yield (TTM)

HRTX-15.8%

NMAD-6.4%

Earnings Yield (TTM)

HRTX-44.3%

NMAD-10.1%

Dividend Yield (TTM)

HRTXN/A

NMADN/A

Rule of 40

HRTX-7.0

NMAD0.0

EV/GP/RG

HRTXN/A

NMADN/A

Ticker research

View HRTX research View NMAD research

Metric	HRTX Heron Therapeutics Inc	NMAD NOMAD Power Solutions, Inc
Market & Valuation
Market Cap	$77M	$86M
Enterprise Value	$199M	$73M
Price	$0.41	$4.53
P/E Ratio	N/A	N/A
P/S Ratio	0.51x	0.00x
EV/Sales	1.31x	0.00x
EV/EBITDA	79.76x	0.00x
P/B Ratio	9.55x	2.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.38x	-13.42x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$151M	$0
Revenue Growth (YoY)	1.0%	N/A
Forward Rev Growth	-1.6%	0.0%
Profitability
Gross Margin (TTM)	70.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-5.8%	0.0%
Net Margin (TTM)	-22.5%	0.0%
FCF Margin (TTM)	-8.0%	N/A
Net Income (TTM)	$-34M	$-9M
FCF (TTM)	$-12M	$-5M
EPS (TTM)	-$0.18	-$0.65
ROE (TTM)	-30090.0%	-7439.0%
ROA (TTM)	-1357.0%	-6203.0%
ROIC (TTM)	-2233.0%	-7439.0%
Financial Health
Cash	$21M	$13M
Debt	$143M	$0
Net Cash/Debt	$-122M	$13M
Current Ratio (TTM)	2.49x	12.87x
Quick Ratio (TTM)	1.44x	12.78x
Debt/Equity (TTM)	20.65x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.65	0.87
52W Performance	-69.9%	-38.3%
YTD Performance	-67.8%	-38.3%
% from 52W High	-74.3%	-41.2%
% from 52W Low	55.6%	45.2%
Efficiency & Yields
Asset Turnover (TTM)	0.60x	0.00x
FCF Yield (TTM)	-15.8%	-6.4%
Earnings Yield (TTM)	-44.3%	-10.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-7.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View HRTX research	View NMAD research